Written by Dr. Eamonn Fahy, MB, BCh, BAO, Ph.D.
Uveitis is an eye condition in which inflammation occurs inside the eye and affects the middle layer of the eye called the uvea. The uvea is a layer of tissue that includes the iris (the coloured part at the front of the eye), and other structures behind the iris (the ciliary body and the choroid). The ciliary body consists of smooth muscles in the eye that help to control the shape of the eye lens when focusing on nearby and distant objects. The choroid is a layer of blood vessels and connective tissue that provides nutrients to the retina.
There are different causes of uveitis, including the presence of autoimmune and inflammatory conditions such as rheumatoid arthritis (a disease that causes the body’s immune system to attack healthy cells, resulting in painful swelling in the joints) and ankylosing spondylitis (a disease that results in a rare type of arthritis causing pain and stiffness in the spine). Infections such as herpes simplex virus and varicella zoster virus or injury caused by trauma can also contribute to the development of uveitis. In many cases, no underlying cause is identified.
The following sections will briefly outline the types of uveitis, public health implications of uveitis, more detail on what causes uveitis, its signs and symptoms, and some insights into its management and treatment.
The type of uveitis is classified based on the location of the eye at which the inflammation occurs. Anterior uveitis has been found to be the most common type of uveitis.
Anterior uveitis affects the front of the eye. It can occur in healthy people with no underlying medical cause. It can occur in one eye or affect both eyes at the same time. Anterior uveitis is also sometimes called iritis as it affects the iris, the coloured part at the front of the eye.
Intermediate uveitis involves the middle portion of the eye and inflammation occurs in the vitreous (a gel-like fluid region of the eye that helps to maintain the round shape of the eye) as well as the peripheral retina (the area of the retina responsible for side and night vision).
Posterior uveitis mainly affects the back of the eye. It involves inflammation in both the retina (the light-sensitive tissue at the back of the eye that converts light into electrical signals to the brain) and choroid (a layer of blood vessels and connective tissue that provides nutrients to the retina).
Pan-uveitis occurs when all the major parts of the eye are affected by inflammation. Behcet’s disease is one of the most well-known causes of pan-uveitis.
Uveitis can affect anyone at any age; however, it mainly affects adults between the ages of 20 to 60 years old . It can also occur in children (below the age of 20 years) but the proportion of children affected with uveitis has been found to be more than 4 times lower compared to adults. A study that was conducted on a database of 14 million people from the United States (US) found the proportion of adults with uveitis to be 12.1 in 10,000 adults while the proportion of children with uveitis to be 2.9 in 10,000 children .
Anterior uveitis is the most common type of uveitis, accounting for more than 50% of cases in many countries such as Germany, the US, South Korea, and India. Intermediate uveitis, posterior uveitis and pan-uveitis are less common with each only accounting for less than 30% of uveitis cases in countries such as the US, India, and Italy. 
The proportion of people who suffer from uveitis varies across different countries. A study published in 2019 revealed that the prevalence of uveitis differs in countries of the Asia-Pacific region, these include India, China, and Japan. Based on the results of the study, the prevalence of uveitis has been estimated to be 31.7 in 10,000 people in India, 15.2 in 10,000 people in China, and 4 in 10,000 people in Japan .
The causes of uveitis also vary by location in the world. Different inflammatory and autoimmune causes are more common in certain parts of the world and in different ethnicities. Uveitis caused by infections such as toxoplasmosis, tuberculosis, and onchocerciasis tends to be more common in developing countries such as South America and Africa.
Given these differences between geographic locations, it is difficult to give a global estimate of the economic burden of uveitis. However, in the United States (US), it is estimated that the cost of treatment for a uveitis patient varies between US$ 935 and US$ 1592 per month, depending on the treatment that the patient is receiving .
In most cases of uveitis, eye health professionals would refer to it as ‘idiopathic’. This means that there is no underlying cause behind the development of uveitis. In other cases, there may be an underlying cause or medical condition causing uveitis to develop. Some of the causes of uveitis are summarised below:
Certain people carry a genetic marker called the HLA-B27 gene; its genetic code translates into a specific protein that is found on the surface of cells. People who carry this gene have a greater risk of developing certain types of autoimmune disorders. These autoimmune disorders can lead to uveitis and can also be linked to inflammation elsewhere in the body, including in the spine (ankylosing spondylitis) and joints (psoriatic arthritis).
Some rare autoimmune conditions such as Behcet’s disease and Vogt-Koyanagi-Harada disease can cause uveitis. Conditions such as sarcoidosis can also cause uveitis, as well as inflammation in the lungs and elsewhere in the body.
Different infections can cause uveitis. Current or past infection, in or around the eye, with herpes simplex virus (cold sore virus) and varicella-zoster virus (Shingles) can commonly cause uveitis. Rarer infections such as cat scratch disease, lyme disease, toxoplasmosis, tuberculosis, and syphilis can also cause uveitis.
Uveitis can commonly occur following trauma to the eye, for example, trauma from being hit by a ball during sports.
Consumption of many medications has been linked to uveitis, but this is a relatively rare cause for uveitis. Antibiotics such as rifabutin, bisphosphonates used to treat osteoporosis, and certain biologic agents such as ipilimumab used to treat cancers are some medications that can cause uveitis.
Rarely, children can be affected by uveitis, which can be linked to an inflammatory joint condition called juvenile idiopathic arthritis (JIA). Children can also develop idiopathic uveitis (with no underlying cause) and uveitis related to other rarer inflammatory conditions and infections.
In rare cases, a type of cancer called lymphoma can cause the development of uveitis.
The most common form of uveitis, anterior uveitis, which affects the front of the eye only, usually presents with the following symptoms:
Rarer forms of uveitis, including intermediate uveitis (middle of the eye) and posterior uveitis (back of the eye) may also cause blurred vision and floaters (shapes moving across the vision). In some cases, this may also lead to a significant reduction in vision.
If you experience any of these signs and symptoms, schedule an appointment with an eye health professional to get your eyes checked. It is also important to note that the development of eye conditions may even start before symptoms appear, which makes going for regular and timely eye checks that much more essential.
In most cases, uveitis responds well to treatment. However, if untreated, uveitis can become more severe, with increased inflammation in the eye and worsening symptoms. This can lead to complications relating to uveitis, such as pupil abnormalities, cataract, and glaucoma (high pressure in the eye). In some cases, these complications are treatable and reversible. In rare cases, these complications can lead to irreversible vision loss.
Uveitis is diagnosed by an eye health professional based on a comprehensive eye check. The most important component of this is the slit lamp examination, where a microscope is used to look at the eye. Inflammation can be seen with this microscope as white blood cells floating in the eye.
Examination also includes looking at the back of the eye (the retina) to look for any signs of inflammation and involves dilating the pupils (making the pupils big) with eye drops in order to see to the back of the eye.
Other investigations such as a scan of the back of the eye (Optical Coherence Tomography/OCT scans) may be used to see certain parts of the eye in more detail by taking cross-section pictures of the eye.
In certain cases, blood tests and other investigations such as a chest X-Ray may be used to look for underlying causes for uveitis.
Uveitis is treated using corticosteroids such as steroidal anti-inflammatory medication. Such medications help to reduce inflammation. Most often, corticosteroids used to treat uveitis are eye drops. Eye drops are also commonly prescribed to dilate the pupil, which can reduce the pain associated with uveitis. Less often, corticosteroid medications may be administered via injections or tablets.
In some cases, where an underlying cause for uveitis is found, medications directed towards that underlying health condition can improve uveitis. Usually, a medical specialist such as a rheumatologist or immunologist will prescribe and supervise these medications.
Uveitis can be a one-off event that never occurs again once treated and resolved. In these cases, an underlying cause for the uveitis is usually not found.
When an underlying cause is linked to the development of uveitis, it is more likely to happen again in the future. Treating the underlying health condition can help to reduce the recurrence of uveitis.
The timely treatment of infections in or around the eye such as shingles and herpes simplex, as well as generalised systemic infections such as tuberculosis and syphilis, can also help to reduce the chances of developing uveitis.
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition or treatment and before undertaking a new healthcare regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.
 Miserocchi, E., Fogliato, G., Modorati, G. and Bandello, F., 2013. Review on the Worldwide Epidemiology of Uveitis. European Journal of Ophthalmology, 23(5), pp.705-717.
 Thorne, J., Suhler, E., Skup, M., Tari, S., Macaulay, D., Chao, J. and Ganguli, A., 2016. Prevalence of Noninfectious Uveitis in the United States. JAMA Ophthalmology, 134(11), p.1237.
 Hsu, Y.-R. et al. Noninfectious uveitis in the Asia–Pacific region. Eye 33, 66–77 (2018).
 Chu, D. S. et al. Healthcare costs and utilization for privately insured patients treated for non-infectious uveitis in the USA. J. Ophthalmic Inflamm. Infect. 3, 64 (2013).
Explore our specifically designed products and services backed by eye health professionals to help keep your children safe online and their eyes healthy.